The loss of neoantigens is an important reason for immune escape in multiple myeloma patients with high intratumor heterogeneity.

The loss of strong-binding neoantigens explains why tumors with high ITH have a higher degree of immune escape and may be feasible for deciding the clinical treatment of MM.